RxDoctor Payments Data

April Anderson

Nurse Practitioner · Angola, INNPI 1275980690

Payments from drug & device makers

$1,393in general payments, 2019–2025

Across 87 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch Health US, LLC$198
  • Sunovion Pharmaceuticals Inc.$188
  • Alkermes, Inc.$166
  • Takeda Pharmaceuticals U.S.A., Inc.$153
  • Teva Pharmaceuticals USA, Inc.$105
  • Neurocrine Biosciences, Inc.$100
  • plus $483 from 13 others

What the payments were for

  • Food & beverage$1,393100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,393 in reported general payments places this provider in the 75th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$2,317
Medicare patients
22
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate11$84,307
Gabapentin83$1,495
Desvenlafaxine Succinate ErDesvenlafaxine Succinate24$1,390
Duloxetine Hcl64$1,150
Lamotrigine73$1,066
Buspirone Hcl33$941
Bupropion XlBupropion Hcl39$911
Hydroxyzine Hcl15$593
Trazodone Hcl73$562
Mirtazapine30$526
Olanzapine11$393
Sertraline Hcl41$307
Nortriptyline Hcl19$226
Quetiapine Fumarate11$174
LoxapineLoxapine Succinate11$156

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$100$84,30711 claims
Teva Pharmaceuticals USA, Inc.Loxapine$105$15611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Angola

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →